Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages
Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy
Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy
View: Text | PDF
Research Article Infectious disease Inflammation

EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages

  • Text
  • PDF
Abstract

Alveolar macrophages (AMs) act as gatekeepers of the lung’s immune responses, serving essential roles in recognizing and eliminating pathogens. The transcription factor (TF) early growth response 2 (EGR2) has been recently described as required for mature AMs in mice; however, its mechanisms of action have not been explored. Here, we identified EGR2 as an epigenomic regulator and likely direct proximal transcriptional activator in AMs using epigenomic approaches (RNA sequencing, ATAC sequencing, and CUT&RUN). The predicted direct proximal targets of EGR2 included a subset of AM identity genes and ones related to pathogen recognition, phagosome maturation, and adhesion, such as Clec7a, Atp6v0d2, Itgb2, Rhoc, and Tmsb10. We provided evidence that EGR2 deficiency led to impaired zymosan internalization and reduced the capacity to respond to Aspergillus fumigatus. Mechanistically, the lack of EGR2 altered the transcriptional response, secreted cytokines (i.e., CXCL11), and inflammation-resolving lipid mediators (i.e., RvE1) of AMs during in vivo zymosan-induced inflammation, which manifested in impaired resolution. Our findings demonstrated that EGR2 is a key proximal transcriptional activator and epigenomic bookmark in AMs responsible for select, distinct components of cell identity and a protective transcriptional and epigenomic program against fungi.

Authors

Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy

×

Figure 4

EGR2 deficiency affects gene networks linked to pathogen recognition and elimination.

Options: View larger image (or click on image) Download as PowerPoint
EGR2 deficiency affects gene networks linked to pathogen recognition and...
(A) Pie charts show the number of unchanged (gray), upregulated (red), downregulated (light blue), or directly downregulated (dark blue; associated with EGR motif–containing peaks) genes in Egr2fl/fl samples that overlap with the core macrophage (Core M), AM-specific TF (AM TFs), and AM signature gene set (AM signature). (B) The log2(fold-change) values of downregulated AM signature DEGs on a column plot separated into 4 groups based on closing DAR association and the presence of EGR motif. (C) The proportional dot plot depicts the enriched KEGG biological pathways related to the 394 repressed and 621 induced genes in Egr2fl/fl (RNA-Seq). The top pathways were selected based on the total number of the target genes and were depicted in that order. (D–F) The row-normalized heatmaps represent the significant expressional changes of phagocytosis-associated genes between Egr2+/+ and Egr2fl/fl AMs for the (D) cytoskeleton organization and function (E) and cell adhesion and movement (F) pathways. The likely directly EGR2-regulated genes are highlighted in blue. (G) The number of the identified significantly up- and downregulated genes and the list of the relatively (dark blue) and absolutely (light blue) EGR2-dependent targets are depicted within the schematic representation of the cellular functions influenced by EGR2. (H) IGV visualization of RNA- and ATAC-Seq coverages and the presence of EGR motifs (highlighted in red) on Egr2+/+ and Egr2fl/fl AMs on 4 selected likely direct EGR2 target genes (overlaid). (I) The columns represent the relative eRNA expression (mean ± SEM) values of selected repressed EGR2-dependent and phagocytosis-related genes’ associated closing DARs with EGR motif in Egr2+/+ (n = 5) and Egr2fl/fl (n = 4) samples (t test, *P ≤ 0.05, **P ≤ 0.01).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts